GBI Spotlight: Dr. Han-Chung Wu

撰文GlobalBio & Investment
日期2024-02-28
GBI Spotlight: Dr. Han-Chung Wu
#GBI Spotlight: Dr. Han-Chung Wu (吳漢忠)

Meet Dr. Han-Chung Wu, the man behind the development of precision therapy through innovative phage display technology. As the Director of BioTrec at NBRP, Academia Sinica, he is a well-known figure in the field of technology transfer and is often referred to as the King of Technology Transfer.

His portfolio of 22 technology transfer cases and the prestigious honor of being elected as a fellow of the National Academy of Inventors in December 2020 speak volumes about his academic achievements.

But what truly sets Dr. Wu apart is his philosophy of life rooted in humility and kindness. He is trusted by many and widely recognized as the driving force behind the promotion of national biotech industry-academia collaboration. We are grateful for the positive impact he has had on the world.

With #Globalbio, let's continue to highlight the contributions of compassionate innovators in the field of biotechnology.

https://lnkd.in/gRfuydpe

BioHub, BioTReC, Sinica Academia